| Citation: | DAI Rong, HAN Shu, XIE Weinan, WANG Baojia, DI Jiamei. Effects of serum HIF-1α and VEGF on vascular calcification in patients with maintenance hemodialysis[J]. Chinese Journal of General Practice, 2025, 23(10): 1672-1675. doi: 10.16766/j.cnki.issn.1674-4152.004202 |
| [1] |
MATSUSHITA K, BALLEW S H, WANG A Y, et al. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease[J]. Nat Rev Nephrol, 2022, 18(11): 696-707. doi: 10.1038/s41581-022-00616-6
|
| [2] |
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2020, 395(10225): 709-733. doi: 10.1016/S0140-6736(20)30045-3
|
| [3] |
RAZZAK M A, FATIMA K, MIAH O F, et al. Risk of abdominal aortic calcifications among end stage renal disease patients under maintenance haemodialysis[J]. Mymensingh Med J, 2019, 28(3): 600-604.
|
| [4] |
PROVENZANO M, COPPOLINO G, FAGA T, et al. Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer[J]. Rev Cardiovasc Med, 2019, 20(4): 209-220. doi: 10.31083/j.rcm.2019.04.548
|
| [5] |
吴祯. 胺基化纤维素对慢性肾脏病大鼠动脉钙化HIF-1α-VEGFA-Notch1通路影响[D]. 保定: 河北大学, 2023.
WU Z. Effect of Amino-Modified Cellulose on the HIF-1α-VEGFA-Notch1 pathway of arterial calcification in rats with chronic kidney disease[D]. Baoding: Hebei University, 2023.
|
| [6] |
SATO N, KAKUTA M, HASEGAWA T, et al. Metagenomic profiling of gut microbiome in early chronic kidney disease[J]. Nephrol Dial Transplant, 2021, 36(9): 1675-1684. doi: 10.1093/ndt/gfaa122
|
| [7] |
KAUPPILA L I, POLAK J F, CUPPLES L A, et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study[J]. Atherosclerosis, 1997, 132(2): 245-250. doi: 10.1016/S0021-9150(97)00106-8
|
| [8] |
MAAS S L, DONNERS M, VAN DER VORST E. ADAM10 and ADAM17, major regulators of chronic kidney disease induced atherosclerosis?[J]. Int J Mol Sci, 2023, 24(8): 7309. DOI: 10.3390/ijms24087309.
|
| [9] |
布海霞, 徐可, 王树龙. 慢性肾脏病患者血清微小RNA-210表达水平及其与颈动脉粥样硬化的关系[J]. 临床内科杂志, 2021, 38(3): 174-177.
BU H X, XU K, WANG S L, et al. Serum micro RNA-210 levels in patients with chronic kidney disease and its relation with carotidartery atherosclerosis[J]. J Clin Intern Med, 2021, 38(3): 174-177.
|
| [10] |
赵心迪, 董洋, 邵凤民, 等. 维持性血液透析患者颈动脉内-中膜厚度与炎性因子的相关性[J]. 中华实用诊断与治疗杂志, 2021, 35(11): 1089-1092.
ZHAO X D, DONG Y, SHAO F M, et al. Correlation of carotid intima-media thickness and inflammatory cytokines in patients with maintenance hemodialysis[J]. J Chin Pract Diagn Ther, 2021, 35(11): 1089-1092.
|
| [11] |
BOVER J, URENA-TORRES P, MATEU S, et al. Evidence in chronic kidney disease-mineral and bone disorder guidelines: is it time to treat or time to wait?[J]. Clin Kidney J, 2020, 13(4): 513-521. doi: 10.1093/ckj/sfz187
|
| [12] |
KOCELAK P, PUZIANOWSKA-KUZNICKA M, OLSZANECKA-GLINIANOWICZ M, et al. Wnt signaling pathway and sclerostin in the development of atherosclerosis and vascular calcification[J]. Adv Clin Exp Med, 2024, 33(5): 519-532.
|
| [13] |
HAN X, MA W, ZHU Y, et al. Advanced glycation end products enhance macrophage polarization to the M1 phenotype via the HIF-1alpha/PDK4 pathway[J]. Mol Cell Endocrinol, 2020, 514: 110878. DOI: 10.1016/j.mce.2020.110878.
|
| [14] |
张倩蓉, 刘杰, 秦钰欣, 等. 高钙摄入对大鼠血管钙化的影响[J]. 沈阳医学院学报, 2023, 25(4): 423-426, 430.
ZHANG Q R, LIU J, QIN Y X, et al. Effect of high calcium intake on vascular calcification in rats[J]. Journal of Shenyang Medical College, 2023, 25(4): 423-426, 430.
|
| [15] |
布合力其·麦麦提, 刘红艳, 冯琦, 等. 行维持性血液透析治疗终末期肾病患者血磷和骨保护素水平变化及与血管钙化的关系[J]. 中华实用诊断与治疗杂志, 2023, 37(5): 489-493.
B H L Q MAIMAITI, LIU H Y, FENG Q, et al. Relationships of serum phosphorus and osteoprotegerin levels with vascular calcification in patients with end-stage renal disease undergoing maintenance hemodialysis[J]. J Chin Pract Diagn Ther, 2023, 37(5): 489-493.
|
| [16] |
黄梦娣, 陈卫东, 刘磊. 维持性血液透析患者血清碱性磷酸酶与钙磷代谢及炎症指标相关性分析[J]. 中华全科医学, 2023, 21(4): 611-614. doi: 10.16766/j.cnki.issn.1674-4152.002942
HUANG M D, CHEN W D, LIU L. Correlation analysis of serum alkaline phosphatase with calcium and phosphorus metabolism and inflammatory makers in maintenance hemodialysis patients[J]. Chinese Journal of General Practice, 2023, 21(4): 611-614. doi: 10.16766/j.cnki.issn.1674-4152.002942
|
| [17] |
NALADO A M, OLORUNFEMI G, DIX-PEEK T, et al. Hepcidin and GDF-15 are potential biomar-kers of iron deficiency anaemia in chronic kidney disease patients in South Africa[J]. BMC nephrology, 2020, 21(1): 1-10. doi: 10.1186/s12882-019-1645-y
|
| [18] |
YANG R, ZHU Y, WANG Y, et al. HIF-1alpha/PDK4/autophagy pathway protects against advanced glycation end-products induced vascular smooth muscle cell calcification[J]. Biochem Biophys Res Commun, 2019, 517(3): 470-476. doi: 10.1016/j.bbrc.2019.07.102
|
| [19] |
陈琪琪, 谭茹瑜, 朱婷婷, 等. 慢性肾脏病血管钙化大鼠模型血清中HIF-1α、β-catenin的表达及意义[J]. 海南医学院学报, 2021, 27(9): 656-660.
CHENG Q Q, TAN R Y, ZHU T T, et al. Significance of detection of serum HIF-1α and β-catenin in rat model of vascular calcification in chronic kidney disease[J]. Journal of Hainan Medical University, 2021, 27(9): 656-660.
|
| [20] |
BALOGH E, TOTH A, MEHES G, et al. Hypoxia triggers osteochondrogenic differentiation of vascular smooth muscle cells in an HIF-1 (hypoxia-inducible factor 1)-dependent and reactive oxygen species-dependent manner[J]. Arterioscler Thromb Vasc Biol, 2019, 39(6): 1088-1099. doi: 10.1161/ATVBAHA.119.312509
|
| [21] |
贺晓雯, 徐玉祥, 张九芝, 等. 行维持性血液透析治疗的患者血清骨桥蛋白、血管内皮生长因子、基质金属蛋白酶9水平及其与血管钙化的关系[J]. 广西医学, 2020, 42(8): 934-937.
HE X W, XU Y X, ZHANG J Z, et al. Serum levels of osteopontin, vascular endothelial growth factor and matrix metalloproteinase 9 and their relationship with vascular calcification in patients undergoing maintenance hemodialysis[J]. Guangxi Medical Journal, 2020, 42(8): 934-937.
|